Google Scholar: https://scholar.google.com/citations?user=FMpEEkUAAAAJ&hl=en
(1) Parker, H. N.; Tao, Y.; Tobin, J.; Haberman, K. L.; Davis, S.; York, E.; Martinez, A.; Matsumoto, N.; Aroujo, J.; Park, J. H.; Zechmann, B.; Kaipparettu, B. A.; Boari, A.; Sayes, C. M.; Evidente, A.; Kornienko, A.; Cravatt, B. F.; Romo, D.; Taube, J. H. Ophiobolin A impacts mitochondrial redox biology in an epithelial-mesenchymal transition (EMT)-specific manner. Cancer Cell Int. 2026. In press.
(2) Liu, Z.; Remsberg, J. R.; Li, H.; Njomen, E.; DeMeester, K. E.; Tao, Y.; Xia, G.; Hayward, R. E.; Yoo, M.; Nguyen, T.; Simon, G. M.; Schreiber, S. L.; Melillo, B.; Cravatt, B. F. Proteomic Ligandability Maps of Spirocycle Acrylamide Stereoprobes Identify Covalent ERCC3 Degraders. J. Am. Chem. Soc. 2024, 146 (15), 10393-10406.
(3) Tao, Y.*; Felber, J. G.*; Zou, Z.*; Njomen, E.; Remsberg, J. R.; Ogasawara, D.; Ye, C.; Melillo, B.; Schreiber, S. L.; He, C.; Remillard, D.; Cravatt, B. F. Chemical Proteomic Discovery of Isotype-Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2. Angew. Chem. Int. Ed. 2023, 62 (51), e202311924.
(4) Reisenauer, K. N.; Aroujo, J.; Tao, Y.; Ranganathan, S.; Romo, D.; Taube, J. H. Therapeutic vulnerabilities of cancer stem cells and effects of natural products. Nat. Prod. Rep. 2023, 40 (8), 1432-1456.
(5) Tao, Y.; Remillard, D.; Vinogradova, E. V.; Yokoyama, M.; Banchenko, S.; Schwefel, D.; Melillo, B.; Schreiber, S. L.; Zhang, X.; Cravatt, B. F. Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1. J. Am. Chem. Soc. 2022, 144 (40), 18688-18699.
(6) Reisenauer, K. N.; Tao, Y.; Das, P.; Song, S.; Svatek, H.; Patel, S. D.; Mikhail, S.; Ingros, A.; Sheesley, P.; Masi, M.; Boari, A.; Evidente, A.; Kornienko, A.; Romo, D.; Taube, J. Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A. Sci. Rep. 2021, 11 (1), 10652.
(7) Abbasov, M. E.; Kavanagh, M. E.; Ichu, T. A.; Lazear, M. R.; Tao, Y.; Crowley, V. M.; Am Ende, C. W.; Hacker, S. M.; Ho, J.; Dix, M. M.; Suciu, R.; Hayward, M. M.; Kiessling, L. L.; Cravatt, B. F. A proteome-wide atlas of lysine-reactive chemistry. Nat. Chem. 2021, 13 (11), 1081-1092.
(8) Tao, Y.; Reisenauer, K. N.; Masi, M.; Evidente, A.; Taube, J. H.; Romo, D. Pharmacophore-Directed Retrosynthesis Applied to Ophiobolin A: Simplified Bicyclic Derivatives Displaying Anticancer Activity. Org. Lett. 2020, 22 (21), 8307-8312.
(9) Tao, Y.; Reisenauer, K.; Taube, J. H.; Romo, D. Total Synthesis and Anticancer Activity of (+)-Hypercalin C and Congeners. Angew. Chem. Int. Ed. 2019, 58 (9), 2734-2738.
(10) Wright, M. H.; Tao, Y.; Drechsel, J.; Krysiak, J.; Chamni, S.; Weigert-Munoz, A.; Harvey, N. L.; Romo, D.; Sieber, S. A. Quantitative chemoproteomic profiling reveals multiple target interactions of spongiolactone derivatives in leukemia cells. ChemComm 2017, 53 (95), 12818-12821.
(11) Tao, Y.; Ding, N.; Ren, S.; Li, Y. Heck-type cross-coupling between halo-exo-glycals and endo-glycals: a practical way to achieve C-glycosidic disaccharides. Tetrahedron Lett. 2013, 54 (45), 6101-6104.